Vicore Pharma: Phase II in SSc Patients on Track
Research Note
2020-08-25
11:43
Redeye gives a brief comment to today’s news that Vicore has resumed recruitment to its Phase II trial with C21 in patients with systemic sclerosis (SSc).
LS
Ludvig Svensson
Disclosures and disclaimers